| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Calendar
|
|
|
1996
|
14 |
10 |
p. 1017-
1 p.
|
artikel
|
| 2 |
Chimeric papilloma virus-like particle; expressed in yeast, mammal or insect cell, and application in recombinant vaccine construction
|
|
|
1996
|
14 |
10 |
p. 1016-
1 p.
|
artikel
|
| 3 |
Construction, purification and immunogenicity of antigen-antibody-LTB complexes
|
Green, E.A.
|
|
1996
|
14 |
10 |
p. 949-958
10 p.
|
artikel
|
| 4 |
Economic aspects of vaccination
|
Demicheli, Vittorio
|
|
1996
|
14 |
10 |
p. 941-943
3 p.
|
artikel
|
| 5 |
Immunization of mice with recombinant L7 L12 ribosomal protein confers protection against Brucella abortus infection
|
Oliveira, Sergio C.
|
|
1996
|
14 |
10 |
p. 959-962
4 p.
|
artikel
|
| 6 |
Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy
|
O'Dempsey, T.J.D.
|
|
1996
|
14 |
10 |
p. 963-970
8 p.
|
artikel
|
| 7 |
Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial
|
Holzer, Benedikt R.
|
|
1996
|
14 |
10 |
p. 982-986
5 p.
|
artikel
|
| 8 |
Immunogenic potential of rgp120 from African HIV-1 subtype A
|
Xie, Jian-Ming
|
|
1996
|
14 |
10 |
p. 993-1000
8 p.
|
artikel
|
| 9 |
Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine
|
McLean, C.S.
|
|
1996
|
14 |
10 |
p. 987-992
6 p.
|
artikel
|
| 10 |
New isolated Helicobacter pylori tagA gene; recombinant TagA antigen preparation, DNA sequence, DNA probe; application in peptic ulceration and gastric carcinoma predisposition determination, diagnosis and recombinant vaccine
|
|
|
1996
|
14 |
10 |
p. 1016-
1 p.
|
artikel
|
| 11 |
New nucleic acid encoding Trypanosoma cruzi epimastigotic antigen; immunogen production by vector expression in e.g. Escherichia coli and insect cell culture, and monoclonal antibody, for application as a Chagas disease recombinant vaccine, and diagnostic
|
|
|
1996
|
14 |
10 |
p. 1016-
1 p.
|
artikel
|
| 12 |
Novel VDJ peptide and corresponding DNA; for use as a recombinant vaccine against insulin-dependent diabetes mellitus by action against anti-p277 anti-idiotype T-lymphocyte cells
|
|
|
1996
|
14 |
10 |
p. 1016-
1 p.
|
artikel
|
| 13 |
Oral vaccination against pseudotuberculosis
|
Thornton, E.A.
|
|
1996
|
14 |
10 |
p. 977-981
5 p.
|
artikel
|
| 14 |
Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine
|
Peeters, C.C.A.M.
|
|
1996
|
14 |
10 |
p. 1009-1015
7 p.
|
artikel
|
| 15 |
Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
|
Claassen, Ivo
|
|
1996
|
14 |
10 |
p. 1001-1008
8 p.
|
artikel
|
| 16 |
Recombinant, octavalent group A streptococcal M protein vaccine
|
Dale, James B.
|
|
1996
|
14 |
10 |
p. 944-948
5 p.
|
artikel
|
| 17 |
Recombinant papilloma virus-like particles containing L1 or L2 proteins; papovavirus fusion protein production in a yeast or baculovirus vector, for application as a recombinant vaccine against cervix carcinoma
|
|
|
1996
|
14 |
10 |
p. 1016-
1 p.
|
artikel
|
| 18 |
The effects of adjuvants on CTL induction by V3:Ty-virus-like particles (V3-VLPs) in mice
|
Harris, S.J.
|
|
1996
|
14 |
10 |
p. 971-976
6 p.
|
artikel
|
Tijdschrift beschrijving